This inventor holds 1 USPTO granted patent. Top assignee: Teijin Pharma Limited. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Motoko Hamada: Innovator in Pharmaceutical Chemistry
Introduction
Motoko Hamada is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that have potential therapeutic applications.
Latest Patents
Hamada holds a patent for "Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof." This patent describes a pyrazolo[1,5-a]pyridine derivative represented by formula (I) and its salts, which exhibit excellent MAPKAP-K2 inhibitory activity. Medicines comprising this compound as an active ingredient are expected to be valuable for treating or preventing diseases mediated by MAPKAP-K2, such as inflammatory injury, autoimmune diseases, asteropathia destruens, cancer, and the growth of tumors. She has 1 patent to her name.
Career Highlights
Motoko Hamada is currently associated with Teijin Pharma Limited, where she continues to work on innovative pharmaceutical solutions. Her research focuses on developing compounds that can address significant health challenges.
Collaborations
Hamada collaborates with notable colleagues, including Gen Unoki and Yoshiyuki Matsumoto, to advance her research and development efforts in the pharmaceutical industry.
Conclusion
Motoko Hamada's work in pharmaceutical chemistry exemplifies the impact of innovative research on healthcare. Her contributions are paving the way for new treatments that could significantly improve patient outcomes.